Allopax
Product Images NDC 69817-0201

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Allopax (NDC 69817-0201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharmagenetico Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Allopax Labels (Allopax Label 101915)

Packaging labels for AlloPAX, marked by PharmaGenetico LLC. Front label notes prescription use, storage at 20°-25°C, protection from light, and handling cautions. Back label clarifies FDA non-approval for disease treatment and lists active ingredients Levocetirizine Dihydrochloride 3g, Loratadine USP 3g in a 60g pack as dispensed.*

FDA Label Image

Allopax Insert (Allopaxinsert)

This text panel describes preparation instructions for AlloPAX Levocetirizine dihydrochloride/Loratadine 5%/5% cream pack by PharmaGenetico LLC. It includes steps for mixing active ingredients and base, storage conditions, disposal instructions, external use warnings, and contact information for PharmaGenetico. Active and inactive ingredient quantities are also listed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.